Toggle navigation
Home
Search
Services
Blog
Contact
About
Phase 1 and Phase 2 Clinical Trials of Cancer Chemopreventive Agents
Search grants from
Share this grant:
:
:
Abstract
Funding
Related projects
Comments
Recent in Grantomics:
Your institution
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
CaM Kinase Cascades in Endocrine Cells
Behavioral Couples Therapy for Women Alcoholic Patients
Behavioral And Environmental Risk Factors For Childhood
Basal Ganglia Circuitry Immediate Early Gene Expression
Radical Mediated DNA Damage in A Model Chromatin System
Recently added grants:
Anticancer peptide therapeutics
BLR&D Research Career Scientist Award Application
Enhancing Community Integration for Homeless Veterans
Functional and neurophysiological effects of a progressive robot assisted gait intervention early post stroke
Next generation in vivo miniature microscopes integrating dual-color imaging, 3D imaging, and optogenetic stimulation with a cloud-compatible data acquisition platform
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research and Development Contracts (N01)
Project #
N01CN35159-7-0-1
Application #
7579651
Study Section
Project Start
2003-09-30
Project End
2008-09-29
Budget Start
Budget End
Support Year
Fiscal Year
2007
Total Cost
Indirect Cost
Related projects
NIH 2008
N01 CA
Phase 1 and Phase 2 Clinical Trials of Cancer Chemopreventive Agents
/ University of Texas MD Anderson Cancer Center
$1,877,000
NIH 2007
N01 CA
Phase I & II Clinical Trials of Chemopreventive Agents
Lippman, Scott M. /
$1,377,221
NIH 2007
N01 CA
Phase 1 and Phase 2 Clinical Trials of Cancer Chemopreventive Agents
/
Comments
Be the first to comment on this grant